In 2030, Berkshire will likely remain a durable pillar of investment stability. Meanwhile, Tesla and Palantir may dazzle ...

OpenAI CEO Sam Altman isn't alone in thinking that investors are overhyping AI.

C3.ai, Inc. AI stock has experienced a significant decline, declining 42.2% over the past month. In fact, AI stock fell ...

C3.ai, Inc. (AI) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider ...

With bad news continuing to pile onto the stock, C3.ai stock has not only plunged to a new 52-week low, it has hit levels it ...

New York, New York-- (Newsfile Corp. - August 21, 2025) - Levi & Korsinsky notifies investors that it has commenced an investigation of C3.ai, Inc. ("C3.ai, Inc.") (NYSE: AI) concerning possible ...

The law firm of Kessler Topaz Meltzer & Check, LLP ( is currently investigating potential violations of the federal securities laws on behalf of investors of C3.ai, Inc. (NYSE: AI) (“C3”). On August 8 ...

C3.ai, Inc. (AI) concluded the recent trading session at $16.94, signifying a -2.53% move from its prior day's close.

Even the most successful companies can see their stocks crash when valuations get this disconnected from reality.

Shares of Palantir ( NASDAQ: PLTR) are falling once again. The stock is down about 2% as of 2 p.m. Wednesday after having ...

Investing.com -- Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) stock surged 23% after the FDA lifted a clinical hold on the company’s pivotal Phase 2 trial of RP-A501 for the treatment of Danon disease.

C3.ai, Inc. (NYSE: AI) is one of the AI Stocks In The Spotlight For Investors. On August 18, C3 AI and Brazilian power ...